Search
Corvus Pharmaceuticals Inc
CRVSAdd to Watchlist
13.260USD
+0.070+0.53%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.12BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Mon, May 11
Updated: Mon, May 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
OrbiMed Advisors, LLC
8.52%
BlackRock Institutional Trust Company, N.A.
5.06%
Adams Street Partners, LLC
3.90%
Vanguard Capital Management, LLC
3.85%
Point72 Asset Management, L.P.
3.42%
Other
75.26%
Shareholders
Shareholders
Proportion
OrbiMed Advisors, LLC
8.52%
BlackRock Institutional Trust Company, N.A.
5.06%
Adams Street Partners, LLC
3.90%
Vanguard Capital Management, LLC
3.85%
Point72 Asset Management, L.P.
3.42%
Other
75.26%
Shareholder Types
Shareholders
Proportion
Investment Advisor
20.02%
Private Equity
14.88%
Investment Advisor/Hedge Fund
13.63%
Hedge Fund
6.31%
Research Firm
4.30%
Individual Investor
3.51%
Venture Capital
3.28%
Pension Fund
0.14%
Bank and Trust
0.11%
Other
33.82%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
248
52.01M
61.85%
+1.01M
2025Q4
198
42.72M
67.87%
+28.18K
2025Q3
198
42.69M
68.03%
+692.60K
2025Q2
185
42.00M
50.82%
+5.57M
2025Q1
150
36.93M
58.80%
-3.14M
2024Q4
137
38.41M
48.94%
+8.38M
2024Q3
107
30.42M
48.36%
+2.42M
2024Q2
103
27.99M
53.72%
-192.26K
2024Q1
112
18.29M
54.96%
-8.66M
2023Q4
115
19.58M
56.23%
-2.90K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
OrbiMed Advisors, LLC
7.17M
8.53%
--
--
Jan 23, 2026
BlackRock Institutional Trust Company, N.A.
4.26M
5.07%
+246.20K
+6.14%
Dec 31, 2025
Adams Street Partners, LLC
3.28M
3.9%
--
--
Jan 23, 2026
Point72 Asset Management, L.P.
2.88M
3.42%
-3.58M
-55.46%
Dec 31, 2025
State Street Investment Management (US)
2.79M
3.32%
+1.78M
+177.07%
Dec 31, 2025
MPM BioImpact LLC
2.74M
3.27%
+2.74M
--
Dec 31, 2025
Morgan Stanley & Co. LLC
2.64M
3.14%
+2.55M
+2791.52%
Dec 31, 2025
Miller (Richard A)
2.32M
2.77%
--
--
Dec 31, 2025
Vivo Capital, LLC
2.23M
2.66%
--
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
1.28%
Invesco NASDAQ Future Gen 200 ETF
0.75%
Tema Oncology ETF
0.72%
iShares Micro-Cap ETF
0.09%
ProShares Ultra Nasdaq Biotechnology
0.08%
Invesco Nasdaq Biotechnology ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
iShares Biotechnology ETF
0.04%
iShares Russell 2000 Growth ETF
0.03%
Proshares Ultra Russell 2000
0.02%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion1.28%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.75%
Tema Oncology ETF
Proportion0.72%
iShares Micro-Cap ETF
Proportion0.09%
ProShares Ultra Nasdaq Biotechnology
Proportion0.08%
Invesco Nasdaq Biotechnology ETF
Proportion0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.05%
iShares Biotechnology ETF
Proportion0.04%
iShares Russell 2000 Growth ETF
Proportion0.03%
Proshares Ultra Russell 2000
Proportion0.02%